Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics.
作者： Win Min Oo , Shirley Pei-Chun Yu , Matthew Sean Daniel , David John Hunter
DOI: 10.1080/14728214.2018.1547706
关键词:
摘要: Introduction: Osteoarthritis (OA) is a leading cause of pain and disability among adults with current prevalence around 15% predicted 35% in 2030 for symptomatic OA. It ...
sci-hub.se 参考文章(168)
Felson Dt, Hannan Mt, Pincus T, Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. The Journal of Rheumatology. ,vol. 27, pp. 1513- ,(2000)
Svetlana Krasnokutsky, Steven Abramson, Biomarkers in osteoarthritis. Bulletin of the NYU hospital for joint diseases. ,vol. 64, pp. 77- 81 ,(2006)
Nieminen R, Vuolteenaho K, Moilanen E, Moilanen T, Järvinen K, Knowles Rg, Selective iNOS inhibitor 1400W enhances anti-catabolic IL-10 and reduces destructive MMP-10 in OA cartilage. Survey of the effects of 1400W on inflammatory mediators produced by OA cartilage as detected by protein antibody array. Clinical and Experimental Rheumatology. ,vol. 26, pp. 275- 282 ,(2008)
STEPHEN D. COOK, LAURA P. PATRON, SAMANTHA L. SALKELD, DAVID C. RUEGER, Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs. Journal of Bone and Joint Surgery, American Volume. ,vol. 85, pp. 116- 123 ,(2003) , 10.2106/00004623-200300003-00018
Felix Eckstein, Marie-Pierre Hellio Le Graverand, Plain radiography or magnetic resonance imaging (MRI): Which is better in assessing outcome in clinical trials of disease-modifying osteoarthritis drugs? Summary of a debate held at the World Congress of Osteoarthritis 2014. Seminars in Arthritis and Rheumatism. ,vol. 45, pp. 251- 256 ,(2015) , 10.1016/J.SEMARTHRIT.2015.06.001
Jean-Pierre Pelletier, Christelle Boileau, Martin Boily, Julie Brunet, François Mineau, Changshen Geng, Pascal Reboul, Stefan Laufer, Daniel Lajeunesse, Johanne Martel-Pelletier, The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Research & Therapy. ,vol. 7, pp. 1- 12 ,(2005) , 10.1186/AR1788
Tim D Spector, Philip G Conaghan, J Christopher Buckland-Wright, Patrick Garnero, Gary A Cline, John F Beary, David J Valent, Joan M Meyer, Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173] Arthritis Research & Therapy. ,vol. 7, pp. 1- 9 ,(2005) , 10.1186/AR1716
T. Kim Le, Leslie B. Montejano, Zhun Cao, Yang Zhao, Dennis Ang, Healthcare Costs Associated with Osteoarthritis in US Patients Pain Practice. ,vol. 12, pp. 633- 640 ,(2012) , 10.1111/J.1533-2500.2012.00535.X
Elena Losina, Alexander M. Weinstein, William M. Reichmann, Sara A. Burbine, Daniel H. Solomon, Meghan E. Daigle, Benjamin N. Rome, Stephanie P. Chen, David J. Hunter, Lisa G. Suter, Joanne M. Jordan, Jeffrey N. Katz, Lifetime Risk and Age at Diagnosis of Symptomatic Knee Osteoarthritis in the US Arthritis Care & Research. ,vol. 65, pp. 703- 711 ,(2013) , 10.1002/ACR.21898
AS Siebuhr, AC Bay-Jensen, JM Jordan, CF Kjelgaard-Petersen, C Christiansen, SB Abramson, M Attur, F Berenbaum, V Kraus, MA Karsdal, Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment? Scandinavian Journal of Rheumatology. ,vol. 45, pp. 87- 98 ,(2016) , 10.3109/03009742.2015.1060259